Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA and Health Care Reform: An Activist Agenda for the Agency

Dec 01 2008

• By Michael McCaughan

Related Content

The Implementer: How the Official Who Will Make FDAAA Work Views the New Law

Dec 01 2007

The Risk of Risk Management

Jan 01 2007

Prioritizing Health Care: Reform Gains Early Momentum

Nov 01 2008

Avoiding Drug Review Limbo

Dec 01 2008

Reinforcements At Last: CDER Hiring Process Well Underway

Jun 01 2008

Regulatory Risk and Business Development: Type 2 Diabetes Falls Out of Favor

Oct 01 2008

Big Pharma May Be Big Player in Follow-On Biologics Market

Apr 01 2008

Additional Topics

Leadership Regulation Reimbursement BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window